Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Testicular germ cell neoplasms.

J D Hainsworth, F A Greco

The American Journal of Medicine

|November 1, 1983

Summary

Advances in chemotherapy have transformed testicular germ cell tumor treatment, significantly improving cure rates. Modern combination chemotherapy, particularly with cis-platinum, offers a high chance of cure for nonseminomatous germ cell tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same author

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

International journal of clinical oncology·2013

Same author

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Same author

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Same author

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.

Cancer treatment reviews·2008

Same author

Diagnostic and therapeutic management of cancer of an unknown primary.

European journal of cancer (Oxford, England : 1990)·2003

Area of Science:

Oncology
Medical Treatment
Cancer Research

Background:

Testicular germ cell neoplasms have seen significant treatment advancements over the past two decades.
Serum tumor markers like alpha-fetoprotein and human chorionic gonadotropin are crucial for diagnosing and staging nonseminomatous neoplasms.

Purpose of the Study:

To review the progress in managing testicular germ cell neoplasms.
To highlight the impact of chemotherapy on nonseminomatous germ cell tumor outcomes.

Main Methods:

Review of recent advancements in testicular germ cell neoplasm management.
Focus on the role of combination chemotherapy regimens, including cis-platinum, vinblastine, and bleomycin.
Consideration of radiotherapy for seminomas and chemotherapy for advanced stages.

Main Results:

Combination chemotherapy has dramatically improved cure rates for nonseminomatous germ cell tumors, changing a high mortality disease to one with a 75% cure rate.
Effective chemotherapy regimens have manageable toxicity, with myelosuppression being a key concern.
Surgical removal of residual disease and VP-16 containing regimens can offer salvage options for refractory cases.

Conclusions:

Testicular germ cell tumor treatment has evolved, with chemotherapy being a cornerstone for nonseminomatous types.
Curative intent and specialized treatment centers are recommended.
Radiotherapy remains effective for most seminomas, but chemotherapy is indicated for advanced stages.

Related Experiment Videos